Cerami A - Search Results

1

Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin.

Collino M, Thiemermann C, Cerami A, Brines M. Collino M, et al. Among authors: cerami a. Pharmacol Ther. 2015 Jul;151:32-40. doi: 10.1016/j.pharmthera.2015.02.005. Epub 2015 Feb 26. Pharmacol Ther. 2015. PMID: 25728128 Free article. Review.

2

The receptor that tames the innate immune response.

Brines M, Cerami A. Brines M, et al. Among authors: cerami a. Mol Med. 2012 May 9;18(1):486-96. doi: 10.2119/molmed.2011.00414. Mol Med. 2012. PMID: 22183892 Free PMC article. Review.

3

Erythropoietin and engineered innate repair activators.

Brines M, Cerami A. Brines M, et al. Among authors: cerami a. Methods Mol Biol. 2013;982:1-11. doi: 10.1007/978-1-62703-308-4_1. Methods Mol Biol. 2013. PMID: 23456859

4

Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.

Brines M, Cerami A. Brines M, et al. Among authors: cerami a. Kidney Int. 2006 Jul;70(2):246-50. doi: 10.1038/sj.ki.5001546. Epub 2006 May 31. Kidney Int. 2006. PMID: 16738535 Free article. Review.

5

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.

Brines M, Cerami A. Brines M, et al. Among authors: cerami a. J Intern Med. 2008 Nov;264(5):405-32. doi: 10.1111/j.1365-2796.2008.02024.x. J Intern Med. 2008. PMID: 19017170 Free article. Review.

6

Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?

Grasso G, Sfacteria A, Cerami A, Brines M. Grasso G, et al. Among authors: cerami a. Neuroscientist. 2004 Apr;10(2):93-8. doi: 10.1177/1073858403259187. Neuroscientist. 2004. PMID: 15070483 Review.

7

Emerging biological roles for erythropoietin in the nervous system.

Brines M, Cerami A. Brines M, et al. Among authors: cerami a. Nat Rev Neurosci. 2005 Jun;6(6):484-94. doi: 10.1038/nrn1687. Nat Rev Neurosci. 2005. PMID: 15928718 Review.

8

A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.

Patel NS, Nandra KK, Brines M, Collino M, Wong WF, Kapoor A, Benetti E, Goh FY, Fantozzi R, Cerami A, Thiemermann C. Patel NS, et al. Among authors: cerami a. Mol Med. 2011 Sep-Oct;17(9-10):883-92. doi: 10.2119/molmed.2011.00053. Epub 2011 May 13. Mol Med. 2011. PMID: 21607291 Free PMC article.

9

Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.

Patel NS, Kerr-Peterson HL, Brines M, Collino M, Rogazzo M, Fantozzi R, Wood EG, Johnson FL, Yaqoob MM, Cerami A, Thiemermann C. Patel NS, et al. Among authors: cerami a. Mol Med. 2012 May 9;18(1):719-27. doi: 10.2119/molmed.2012.00093. Mol Med. 2012. PMID: 22415011 Free PMC article.

10

Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.

Ahmet I, Tae HJ, Brines M, Cerami A, Lakatta EG, Talan MI. Ahmet I, et al. Among authors: cerami a. J Pharmacol Exp Ther. 2013 Jun;345(3):446-56. doi: 10.1124/jpet.113.202945. Epub 2013 Apr 12. J Pharmacol Exp Ther. 2013. PMID: 23584743 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

453 results

Search Page

Filters